Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|November 17, 2006
Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophoreJohn M Keith, Leslie A Gomez, Michael A Letavic, et al.HIV Medicine|November 5, 2020
Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-PacificJ Ross, A Jiamsakul, N Kumarasamy, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitorsKiev S Ly, Michael A Letavic, John M Keith, et al.The British Journal of Dermatology|April 14, 2017
Study of gene expression alteration in male androgenetic alopecia: evidence of predominant molecular signalling pathwaysL Michel, P Reygagne, P Benech, et al.AIDS (London, England)|August 10, 2019
Emotional and behavioral resilience among children with perinatally acquired HIV in Thailand and CambodiaKathleen M Malee, Stephen Kerr, Robert Paul, et al.Journal of Medicinal Chemistry|June 19, 2015
Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical CandidateMichael A Letavic, Pascal Bonaventure, Nicholas I Carruthers, et al.Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonistsEmily M Stocking, Leah Aluisio, John R Atack, et al.Journal of the International AIDS Society|June 11, 2019
Impact of the frequency of plasma viral load monitoring on treatment outcomes among children with perinatally acquired HIVTavitiya Sudjaritruk, David C Boettiger, Lam Van Nguyen, et al.Journal of Medicinal Chemistry|September 5, 2003
The first potent and selective non-imidazole human histamine H4 receptor antagonistsJill A Jablonowski, Cheryl A Grice, Wenying Chai, et al.Haematologica|November 21, 2024
Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killingYael Morgenstern, JongBok Lee, Yoosu Na, et al.Pageof 8